Vigil Neuroscience, Inc. (VIGL)
Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed on myeloid cells 2 (TREM2) which is in Phase I for the treatment of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia, as well as for the treatment of cerebral adrenoleukodystrophy and alzheimer's disease. The company also develops a small molecule TREM2 agonist suitable for oral delivery to treat common neurodegenerative diseases associated with microglial dysfunction. Vigil Neuroscience, Inc. was incorporated in 2020 and is headquartered in Cambridge, Massachusetts.
$135.99M
Dr. Ivana Magovcevic-Liebisch J.D., Ph.D.
52.00
Cambridge, MA
Jan 07, 2022
-1.63
$-2.11
7.19
19.07
0.00%
-3.01
0.82
0.00
18.39
-23.92%
-23.30%
Similar stocks (11)
Edgewise Therapeutics, Inc.
EWTX
Tyra Biosciences, Inc.
TYRA
Cullinan Oncology, Inc.
CGEM
Third Harmonic Bio, Inc.
THRD
Entrada Therapeutics, Inc.
TRDA
PureTech Health plc
PRTC
Monte Rosa Therapeutics, Inc.
GLUE
PepGen Inc.
PEPG
Compass Therapeutics, Inc.
CMPX
PMV Pharmaceuticals, Inc.
PMVP
Rallybio Corporation
RLYB
ETF Exposure (12)
BlackRock Future Health ETF
BMED
0.0431%
iShares Micro-Cap ETF
IWC
0.01716%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (11)
Edgewise Therapeutics, Inc.
EWTX
Tyra Biosciences, Inc.
TYRA
Cullinan Oncology, Inc.
CGEM
Third Harmonic Bio, Inc.
THRD
Entrada Therapeutics, Inc.
TRDA
PureTech Health plc
PRTC
Monte Rosa Therapeutics, Inc.
GLUE
PepGen Inc.
PEPG
Compass Therapeutics, Inc.
CMPX
PMV Pharmaceuticals, Inc.
PMVP
Rallybio Corporation
RLYB
ETF Exposure (12)
BlackRock Future Health ETF
BMED
0.0431%
iShares Micro-Cap ETF
IWC
0.01716%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%